Jennifer K. Hoffman - Concepedia

Author

Jennifer K. Hoffman

Pfizer (United States)

Also Known As

Jennifer Hoffman, Jennifer K. Hoffman

Publications

160

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Sanford Burnham Prebys Medical Discovery Institute

About

Jennifer K. Hoffman is an author at Pfizer (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	114
2	Pharmacology	4	4	114
3	Drug Discovery	3	3	52
4	Biochemistry	2	2	85
5	Neuroscience	1	1	23

Jennifer K. Hoffman

Publications

156

Citations

H-Index

Page 1

	Year	Citations
Dual neuroprotective pathways of a pro‐electrophilic compound via HSF‐1‐activated heat‐shock proteins and Nrf2‐activated phase 2 antioxidant response enzymes Takumi Satoh, Tayebeh Rezaie, Masaaki Seki, Journal of Neurochemistry Redox SignalingBiochemistrySuch Dihydroquinones FunctionMedicineDna Microarray	2011	62
Isolation, Synthesis, and Biological Activity of Aphrocallistin, an Adenine-Substituted Bromotyramine Metabolite from the Hexactinellida Sponge <i>Aphrocallistes beatrix</i> Amy E. Wright, Gregory P. Roth, Jennifer K. Hoffman, Journal of Natural Products	2009	28
Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists Jared B. J. Milbank, Christopher S. Knauer, Corinne E. Augelli‐Szafran, Bioorganic & Medicinal Chemistry Letters BiochemistryFunctional SelectivityRational DesignMedicineRational Drug Design	2007	23
Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase Noel A. Powell, Jennifer K. Hoffman, Fred L. Ciske, Bioorganic & Medicinal Chemistry Letters MedicinePharmacological AgentPharmacotherapyAnti-cancer AgentPharmacology	2012	15
Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase Noel A. Powell, Jennifer K. Hoffman, Fred L. Ciske, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineRational Drug DesignPharmacotherapyAnti-cancer Agent	2012	14
(1 ,2 )-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production Lain‐Yen Hu, Daniel Du, Jennifer K. Hoffman, Bioorganic & Medicinal Chemistry Letters	2007	14

Page 1